Neurofibromatosis and interstitial lung disease

Area of Science:

• Pulmonary Medicine
• Genetics
• Radiology

Background:

• Neurofibromatosis is a genetic disorder with diverse clinical manifestations.
• Interstitial lung disease (ILD) is a recognized, though less common, complication in adult patients with neurofibromatosis.
• Understanding the spectrum of thoracic involvement is crucial for comprehensive patient management.

Observation:

• The case presented highlights key radiological features of neurofibromatosis-associated ILD.
• Observed characteristics include bilateral lower lobe fibrosis.
• Advanced stages may exhibit bullous and cystic lung changes.

Findings:

• Literature estimates 10-20% of adult neurofibromatosis patients develop ILD.
• Fibrotic changes predominantly affect the lower lung lobes.
• Other intrathoracic associations such as neurofibromas and meningoceles can coexist.

Implications:

• Early recognition of pulmonary manifestations can guide timely intervention.
• Awareness of ILD in neurofibromatosis improves diagnostic accuracy.
• Further research into the pathogenesis and treatment of neurofibromatosis-related lung disease is warranted.